Used as a key chiral intermediate in the synthesis of fluoroquinolone antibiotics, particularly in the production of advanced antimicrobial agents. Its stereochemistry enhances the binding affinity to bacterial DNA gyrase and topoisomerase IV, improving potency against resistant strains. Employed in pharmaceutical research to develop novel quinolone derivatives with optimized pharmacokinetic profiles and reduced side effects. Also utilized in asymmetric synthesis routes where enantiomeric purity is critical for biological activity.